ReviewCurrent hematologic malignancy reports2024

Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma.

Darren Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.